The influence of nutritional status and disease on adiponectin and TNF-α levels in colorectal cancer patients;Influencia del estado nutritivo y la enfermedad sobre las concentraciones de adiponectina y TNF α & en pacientes con cáncer colorrectal

Nutricion Hospitalaria

Volumn 30, Issue 1, 2014, Pages 140-146

  Vicente, Mariana Abe ^a   Silva, Tiago Donizetti ^a   Barão, Katia ^a   Felipe, Aledson Vitor ^a   Missae, Lila Oyama ^a   Forones, Nora Manoukian ^a  

^a Departament of Medicine Gastroenterology Division Oncology Group ^*  (Brazil)

Author keywords

Adipocytokines; Colorectal cancer; Nutrition assessment

Indexed keywords

ADIPONECTIN; ADIPOQ PROTEIN, HUMAN; TUMOR NECROSIS FACTOR ALPHA;

BLOOD; CANCER STAGING; COLORECTAL TUMOR; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; MALE; MIDDLE AGED; NUTRITIONAL STATUS; PATHOLOGY; PATHOPHYSIOLOGY;

ADIPONECTIN; COLORECTAL NEOPLASMS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; NUTRITIONAL STATUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84940234193     PISSN: 02121611     EISSN: 16995198     Source Type: Journal    
DOI: 10.3305/nh.2014.30.1.7132     Document Type: Article

References (33)

1. Siegel EM, Ulrich CM, Poole EM, Holmes RS, Jacobsen PB, Shibata D. The effects of obesity and obesity-related conditions on colorectal cancer prognosis. Cancer Control. 2010; 17 (1): 52-7.
2. VanKruijsdijk RC, Van Der Wall E, Visseren F.L. Obesity and cancer: the role of dysfunctional adipose tissue. Cancer Epidemiol Biomarkers Prev 2009; 18 (10): 2569-78.
3. Hopkins MH, Flanders WD, Bostick R.M. Associations of circula-ting inflammatory biomarkers with risk factors for colorectal cancer in colorectal adenoma patients. Biomark Insights 2012; 7: 143-50.
4. Nicholas J. Roberts, Shibin Zhou, Luis A. Diaz Jr., Matthias Holdhoff. Systemic use of tumor necrosis factor alpha as an anticancer agent. Oncotarget 2011; 2 (10): 739-51.
5. Kim KY, Kim JK, Jeon JH, Yoon SR, Choi I and Yang Y: c-Jun N-terminal kinase is involved in the suppression of adiponectin expression by TNF-alpha in 3T3-L1 adipocytes. Biochem Biophys Res Commun 2005; 327 (2): 460-7.
6. Kumor A, Daniel P, Pietruczuk M, Małecka-Panas E. Serum leptin, adiponectin, and resistin concentration in colorectal adenoma and carcinoma (CC) patients. Int J Colorectal Dis 2009; 24 (3): 275-81.
7. An W, Bai Y, Deng SX, Gao J, Ben QW, Cai QC, et al. Adiponectin levels in patients with colorectal cancer and adenoma: a meta-analysis. Eur J Cancer Prev 2012; 21 (2): 126-33.
8. Hillenbrand A, Fassler J, Huber N, Xu P, Henne-Bruns D, Templin M, et al. Changed adipocytokine concentrations in colorectal tumor patients and morbidly obese patients compared to healthy controls. BMC Cancer 2012; 23; 12: 545.
9. Jamieson NB, Brown DJ, Michzel Wallace A, McMillan D.C. Adiponectin and the systemic inflammatory response in weightlosing patients with non-small cell lung cancer. Cytokine 2004; 27 (2-3): 90-2.
10. Li H, Yang G, Xiang YB, Gao J, Zhang X, Zheng W, et al. Body weight, fat distribution and colorectal cancer risk: a report from cohort studies of 134 255 Chinese men and women. Int J Obes (Lond) 2012; Sep 18.
11. Thibault R, Genton L, Pichard C. Body composition: Why, when and for who? Clin Nutr 2012; 31 (4): 435-47.
12. Llames L, Baldomero V, Iglesias ML, Rodota L.P. Values of the phase angle by bioelectrical impedance; nutritional status and prognostic value. Nutr Hosp 2013; 28 (2): 286-95.
13. Kyle UG, Soundar EP, Genton L, Pichard C. Can phase angle determined by bioelectrical impedance analysis assess nutritional risk? A comparison between healthy and hospitalized subjects. Clin Nutr 2012; 31 (6): 875-81.
14. Ottery F.D. Definition of standardized nutritional assessment and interventional pathways in oncology. Nutrition 1996; 12 (Supl. 1): S15-9.
15. Ottery F.D. Patient-Generated Subjective Global Assessment. In: The Clinical Guide to Oncology Nutrition, ed. PD McCallum & CG Polisena. The American Dietetic Association 2000. pp. 11-23.
16. Bauer J, Capra S, Ferguson M. Use of the scored Patient-Gene-rated Subjective Global Assessment (PG-SGA) as a nutrition assessment tool in patients with cancer. Eur J Clin Nutr 2002; 56 (8): 779-85.
17. Kim HJ, Kim HJ, Yun J, Kim KH, Kim SH, Lee SC, et al. Pathophysiological role of hormones and cytokines in cancer cache-xia. J Korean Med Sci 2012; 27 (2): 128-34.
18. Sobin LH, Gospodarowicz MK, Wittekind Ch (eds): TNM Classification of Malignant Tumours (ed 7). West Sussex, United Kingdom, Wiley-Blackwell, 2009.
19. Organización Mundial de la Salud. El estado físico: uso e interpretación de la antropometría. Genebra: OMS; 1995. p. 452.
20. [No authors listed]. NIH Consensus statement. Bioelectrical impedance analysis in body composition measurement. National Institutes of Health Technology Assessment Conference Statement. December 12-14, 1994. Nutrition 1996; 12 (11-12): 749-62.
21. Gonzalez MC, Borges LR, Silveira DH, Assunção MCF, Orlandi S.P. Validação da versão em português da avaliação subjetiva global produzida pelo paciente. Rev Bras Nutr Clin 2010; 25 (2): 102-8.
22. Gonullu G, Kahraman H, Bedir A, Bektas A, Yücel I. Association between adiponectin, resistin, insulin resistance, and co-lorectal tumors. Int J Colorectal Dis 2010; 25 (2): 205-12.
23. Balkwill F. Tumour necrosis factor and cancer. Nat Rev Cancer 2009; 9 (5): 361-71.
24. Li B, Vincent A, Cates J, Brantley-Sieders DM, Polk DB, Young P.P. Low levels of tumor necrosis factor alpha increase tumor growth by inducing an endothelial phenotype of monocytes recruited to the tumor site. Cancer Res 2009; 69 (1): 338-48.
25. Grimm M, Lazariotou M, Kircher S, Höfelmayr A, Germer CT, von Rahden BH, et al. Tumor necrosis factor-is associated with positive lymph node status in patients with recurrence of colorectal cancer-indications for anti-TNF-α agents in cancer treatment. Anal Cell Pathol (Amst) 2010; 33 (3): 151-63.
26. Ren L, Zhu D, Wei Y, Pan X, Liang L, Xu J, et al. Enhanced Recovery After Surgery (ERAS) Program Attenuates Stress and Accelerates Recovery in Patients After Radical Resection for Colorectal Cancer: A Prospective Randomized Controlled Trial. World J Surg 2012; 36: 407-14.
27. Zhang HH, Halbleib M, Ahmad F, Manganiello VC, Greenberg A.S. Tumor necrosis factor-alpha stimulates lipolysis in differentiated human adipocytes through activation of extracellular signal-related kinase and elevation of intracellular cAMP. Diabetes 2002; 51 (10): 2929-35.
28. Yamaji T, Iwasaki M, Sasazuki S, Tsugane S. Interaction bet-ween Adiponectin and Leptin Influences the Risk of Colorectal Adenoma. Cancer Res 2010; 70 (13): 5430-7.
29. Guadagni F, Roselli M, Martini F, Spila A, Riondino S, D'Alessandro R, et al. Prognostic significance of serum adipokine levels in colorectal cancer patients. Anticancer Res 2009; 29 (8): 3321-7.
30. Gupta D, Lis CG, Dahlk SL, King J, Vashi PG, Grutsch JF, et al. The relationship between bioelectrical impedance phase angle and subjective global assessment in advanced colorectal cancer. Nutr J 2008. pp. 7-19.
31. Norman K, Stobäus N, Zocher D, Bosy-Westphal A, Szramek A, Scheufele R, et al. Cutoff percentiles of bioelectrical phase angle predict functionality, quality of life, and mortality in patients with cancer. Am J Clin Nutr 2010; 92 (3): 612-9.
32. Abe Vicente M; Barão K, Silva TD, Forones N.M. What are the most effective methods for assessment of nutritional status in outpatients with gastric and colorectal cancer. Nutr Hosp 2013; 28 (3): 585-91.
33. Correia M, Cravo M, Marques-Vidal P, Grimble R, Dias-Pereira A, Faias S, et al. Serum concentrations of TNF-alpha as a surrogate marker for malnutrition and worse quality of life in patients with gastric cancer. Clin Nutr 2007; 26 (6): 728-35.